Fenix 2+

SKU: FNX2+ 6971969669932

1 x FENiX 2+ Vaporiser
1 x USB Type-C Charging Cable
1 x Cleaning Brush
1 x Packing Tool
1 x Replacement Screens Set
1 x User Manual

• Heating Technology: Patented Convection (AIR HEATING®)
• Temperature Range: Fully adjustable up to 220°C
• Battery: 4800mAh, fast-charging with USB Type-C
• Heat-Up Time: 10-30 seconds
• Timer Settings: Adjustable auto-shutoff (3-7 minutes)
• Mouthpiece: Zirconium ceramic for cool, pure vapour
• Air Path: Stainless steel with built-in air ducts and cooling system
• Display: 0.96-inch OLED screen
• Design: Rugged and portable

TGA Notified Supply

Authorised Hardware: All products are unfilled, non-medicated Cannabis Vaping Devices imported under Regulation 5A of the Customs (Prohibited Imports) Regulations 1956.

Compliance Infrastructure: Instavape Australia manages all Essential Principles (EPs), technical notifications, and mandatory 6-monthly volume reporting to the TGA.

Device Standards: Hardware is supplied based on technical safety and notification status.

The Line in the Sand

Clinical Autonomy: Our role is strictly limited to the supply of the TGA- Notified products and devices. The determination of patient suitability, the selection of therapeutic substances, and the verification of prescribing authorisations are the exclusive professional responsibility of the dispensing pharmacist.

Information vs. Advice: We provide technical specifications and notification data to support pharmacy due diligence. We provide no clinical guidance, medical advice, or treatment recommendations.

Data Isolation: As we do not supply scheduled substances.

B2B Credentialing: In accordance with the Therapeutic Goods (Vaping Goods—Advertising) Authorisation 2024, access to this product data is restricted to AHPRA-registered professionals and authorised clinical purchasing officers.

Advertising Compliance: This information is provided for the clinical supply chain and is not for public display or consumer-facing promotion.

Hardware Sponsorship: Instavape Australia acts solely as the Hardware Sponsor. Liability for clinical outcomes rests entirely with the prescribing and dispensing practitioners.